ADAPTIVE BIOTECHNOLOGIES (ADPT)

US00650F1093 - Common Stock

2.61  +0.01 (+0.38%)

After market: 2.61 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
154.3M
56.81%		185.3M
20.09%		170.276M
-8.11%		179.34M
5.32%
EBITDA
YoY % growth
-195M
-35.14%		-177.7M
8.87%		-179.375M
-0.94%		-116.056M
35.30%
EBIT
YoY % growth
-209M
-36.78%		-198.6M
4.98%		-201.606M
-1.51%		-173.635M
13.87%
Operating Margin
-135.45%-107.18%-118.40%-96.82%
EPS
YoY % growth
-1.47
-32.43%		-1.41
4.08%		-1.38
2.13%		-1.32
4.23%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.35
12.94%
Revenue
Q2Q % growth		39.56M
5.07%
EBITDA
Q2Q % growth		-32.663MN/AN/AN/AN/A
EBIT
Q2Q % growth		-48.216M
15.69%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.30
-7.14%		-0.340.0411.21%
Q3 2023
Q2Q % growth		 -0.35
-9.37%		-0.350.00-1.25%
Q2 2023
Q2Q % growth		 -0.33
10.81%		-0.350.026.66%
Q1 2023
Q2Q % growth		 -0.40
9.09%		-0.38-0.02-4.08%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 45.784M
-17.06%		49.427M-3.643M-7.37%
Q3 2023
Q2Q % growth		 37.92M
-20.72%		43.822M-5.902M-13.47%
Q2 2023
Q2Q % growth		 48.93M
12.07%		45.785M3.145M6.87%
Q1 2023
Q2Q % growth		 37.65M
-2.51%		37.547M103K0.27%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.51% -7.18% 1.09% -12.79%
Revenue1.5% -17.93% 0.12% -21.55%